Grace and Chevron have big plans for their catalyst joint-venture Advanced Refining Technologies: Together, the companies plan to spend around US $ 135 in a worldscale catalyst production site in Louisiana.

Nobody doubts that digitalization is the key to comprehensive process control. That is why Fieldbus H1 and Profibus PA are at the core of any new system. They not only enable digitalizing process control from the PCS all the way down to each individual device. They also pave the way for the big data approach of a new generation of production control.

Modified 3-phase-decanter blows up hydraulic borders—The designers of Pieralisi have modified the 3-phase-decanter far reaching. Tests in the biodiesel-production agreed a growth in output of 270%.

Mexichem's subsidiary Dura-Line hast openend its production plant for ducts and pressure pipes for the water, datacom and gas markets in Hyderabad, India.

West African pharmaceutical pioneer relies on Bosch sterilizer — Medicine is in short supply in sub-Saharan Africa — even basic medications are difficult to obtain. This led Dr Guy Dovi-Akué to give up his position as chief physician at a German hospital and return to his homeland of Togo, where he founded a pharmaceutical company.

Vacuum dryer system for API, fine chemicals and intermediates—Maximum ease of cleaning, maintenance and internal inspection even for multi-product applications: The horizontal paddle vacuum dryer by Italvacuum is the result of a deep analysis, conducted in cooperation with the most demanding operators, regarding the most urgent requirements of their production.

Akzo Nobel's Specialty Chemicals business has completed a $ 10 million investment at its LeMoyne sulfur derivatives plant in the US, which supplies ingredients used in several major industries.

"In 2016, a worldwide turnover of almost $ 31 billion was achieved with surfactants," says Oliver Kutsch, CEO of Ceresana. The institute expects another growth of revenues of surfactants of, on average 3.1 % per year.

Novartis will commence a tender offer upon completion of works council consultation and AAA’s Board of Directors recommending the tender offer to its shareholders. The deal will help the company to strengthen its oncology portfolio with both near-term product launches as well as a new technology platform.

The company has sold its shares in its joint venture, Hisun-Pfizer Pharmaceuticals, to Sapphire I (HK) Holdings. Post the transfer, the joint venture will retain its current rights to manufacture, sell and distribute the company’s products in China.